{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:27:24Z","timestamp":1783441644233,"version":"3.54.6"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The effect of mental disorders (MD) on cardiovascular disease (CVD) remains controversial, and this study aims to analyze the causal relationship between eight MD and CVD by Mendelian randomization (MR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Single nucleotide polymorphisms of attention-deficit\/hyperactivity disorder (ADHD), anorexia nervosa (AN), anxiety disorder (ANX), autism spectrum disorder (ASD), bipolar disorder (BD), depression, obsessive-compulsive disorder (OCD), schizophrenia (SCZ), and CVD were obtained from UK Biobank and FinnGen. Exposure-outcome causality was tested using inverse variance weighted (IVW), MR-Egger, and weighted median. Horizontal pleiotropy and heterogeneity were assessed by MR-Egger intercept and Cochran's Q, respectively, while stability of results was assessed by leave-one-out sensitivity analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>MR analysis showed that ANX (IVW [odds ratio (OR) 1.11, 95% confidence intervals (CI) 1.07\u20131.15, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001]; MR-Egger [OR 1.03, 95% CI 0.92\u20131.14, <jats:italic>p<\/jats:italic>\u2009=\u20090.652]; weighted median [OR 1.09, 95% CI 1.03\u20131.14, <jats:italic>p<\/jats:italic>\u2009=\u20090.001]), ASD (IVW [OR 1.05, 95% CI 1.00\u20131.09, <jats:italic>p<\/jats:italic>\u2009=\u20090.039]; MR-Egger [OR 0.95, 95% CI 0.84\u20131.07, <jats:italic>p<\/jats:italic>\u2009=\u20090.411]; weighted median [OR 1.01, 95% CI 0.96\u20131.06, <jats:italic>p<\/jats:italic>\u2009=\u20090.805]), depression (IVW [OR 1.15, 95% CI 1.10\u20131.19, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001]; MR-Egger [OR 1.10, 95% CI 0.96\u20131.26, <jats:italic>p<\/jats:italic>\u2009=\u20090.169]; weighted median [OR 1.13, 95% CI 1.08\u20131.19, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001]) were significantly associated with increased risk of CVD, whereas ADHD, AN, BD, OCD, and SCZ were not significantly associated with CVD (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). Intercept analysis showed no horizontal pleiotropy (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). Cochran's Q showed no heterogeneity except for BD (<jats:italic>p<\/jats:italic>\u2009=\u20090.035). Sensitivity analysis suggested that these results were robust.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ANX, ASD, and depression are associated with an increased risk of CVD, whereas AN, ADHD, BD, OCD, and SCZ are not causally associated with CVD. Active prevention and treatment of ANX, ASD, and depression may help reduce the risk of CVD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1329463","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T04:31:33Z","timestamp":1717389093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A Mendelian randomization study of the effect of mental disorders on cardiovascular disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Yunfeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10916-020-01682-8","article-title":"Data mining for cardiovascular disease prediction","volume":"45","author":"Martins","year":"2021","journal-title":"J Med Syst"},{"key":"B2","doi-asserted-by":"publisher","first-page":"105510","DOI":"10.1016\/j.phrs.2021.105510","article-title":"miR-29 family: a potential therapeutic target for cardiovascular disease","volume":"166","author":"Liu","year":"2021","journal-title":"Pharmacol Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001077","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American heart association","volume":"146","author":"O\u2019Sullivan","year":"2022","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.15836\/ccar.2013.373","article-title":"Morbidity and mortality from cardiovascular diseases","volume":"8","author":"Kralj","year":"2013","journal-title":"Cardiol Croat"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11936-017-0545-3","article-title":"Cardiovascular disease prevention: the role of policy interventions","volume":"19","author":"Oseran","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1559827620910981","article-title":"The North Karelia project: prevention of cardiovascular disease in Finland through population-based lifestyle interventions","volume":"14","author":"Puska","year":"2020","journal-title":"Am J Lifestyle Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","article-title":"Prevalence and prevention of cardiovascular disease and diabetes mellitus","volume":"113","author":"Balakumar","year":"2016","journal-title":"Pharmacol Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/2047487317691875","article-title":"Epidemiology and prevention of cardiovascular disease: quo vadis?","volume":"24","author":"De Backer","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"102063","DOI":"10.1016\/j.eclinm.2023.102063","article-title":"Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries","volume":"61","author":"Shen","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2008.10.002","article-title":"The impact of mental illness on cardiac outcomes: a review for the cardiologist","volume":"132","author":"Sowden","year":"2009","journal-title":"Int J Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"00333","DOI":"10.1016\/j.schres.2022.08.027","article-title":"Mitochondrial dysfunction in psychiatric disorders","author":"Ni","year":"2022","journal-title":"Schizophr Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42826-020-00039-z","article-title":"Rodent models for psychiatric disorders: problems and promises","volume":"36","author":"Baker","year":"2020","journal-title":"Lab Anim Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"101755","DOI":"10.1016\/j.cpcardiol.2023.101755","article-title":"Rising burden of cardiovascular disease risk factors and acute cardiac events in young adults with comorbid depression: a comparison nationwide US cohorts hospitalized 10-years apart","volume":"48","author":"Vyas","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12933-023-01809-4","article-title":"Impact of mental disorders on the risk of heart failure among Korean patients with diabetes: a cohort study","volume":"22","author":"Yoo","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"Jama"},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"114999","DOI":"10.1016\/j.biopha.2023.114999","article-title":"Cardiovascular disease treatment using traditional Chinese medicine: mitochondria as the achilles\u2019 heel","volume":"164","author":"Gao","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","article-title":"Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting","volume":"159","author":"Soppert","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/YCO.0000000000000797","article-title":"Cardiovascular disease risk in people with severe mental disorders: an update and call for action","volume":"35","author":"R\u00f8devand","year":"2022","journal-title":"Curr Opin Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.jacc.2018.03.458","article-title":"Psychopharmacology and cardiovascular disease","volume":"71","author":"Pi\u00f1a","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12872-020-01794-6","article-title":"Controlled direct effect of psychiatric disorders on cardiovascular disease: evidence from a large kurdish cohort","volume":"20","author":"Darabi","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ehf2.14676","article-title":"Anxiety disorder and cardiovascular disease: a two-sample Mendelian randomization study","volume":"11","author":"Peng","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"676030","DOI":"10.3389\/fcvm.2021.676030","article-title":"Association of autism Spectrum disorder, neuroticism, and subjective well-being with cardiovascular diseases: a two-sample Mendelian randomization study","volume":"8","author":"Sun","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e017986","DOI":"10.1161\/JAHA.120.017986","article-title":"Genetic liability to depression and risk of coronary artery disease, myocardial infarction, and other cardiovascular outcomes","volume":"10","author":"Lu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/schbul\/sbab132","article-title":"Exploring the relationship between schizophrenia and cardiovascular disease: a genetic correlation and multivariable Mendelian randomization study","volume":"48","author":"Veeneman","year":"2022","journal-title":"Schizophr Bull"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1186\/s12889-022-14143-3","article-title":"Interaction of sleep duration and depression on cardiovascular disease: a retrospective cohort study","volume":"22","author":"Jin","year":"2022","journal-title":"BMC Public Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jad.2022.03.005","article-title":"Depression duration and risk of incident cardiovascular disease: a population-based six-year cohort study","volume":"305","author":"Zhang","year":"2022","journal-title":"J Affect Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.1016\/j.psycom.2023.100125","article-title":"Depression, physical activity, and incident cardiovascular disease among American Indians: the strong heart family study","volume":"3","author":"Staff","year":"2023","journal-title":"Psychiatry Res Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjmed.2023.04.036","article-title":"Association of depression and cardiovascular disease","volume":"136","author":"Krittanawong","year":"2023","journal-title":"Am J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"107710","DOI":"10.1016\/j.jdiacomp.2020.107710","article-title":"Depression and cardiovascular disease events among patients with type 2 diabetes: a systematic review and meta-analysis with bias analysis","volume":"34","author":"Inoue","year":"2020","journal-title":"J Diabetes Complications"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41380-019-0395-3","article-title":"Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort","volume":"25","author":"Khandaker","year":"2020","journal-title":"Mol Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2174\/1389200219666180305143501","article-title":"Current therapeutic approaches for targeting inflammation in depression and cardiovascular disease","volume":"19","author":"Zuzarte","year":"2018","journal-title":"Curr Drug Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1073\/pnas.1118355109","article-title":"Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk","volume":"109","author":"Cohen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"112802","DOI":"10.1016\/j.psychres.2020.112802","article-title":"Depression and cardiovascular disease: shared molecular mechanisms and clinical implications","volume":"285","author":"Shao","year":"2020","journal-title":"Psychiatry Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/qjmed\/hci064","article-title":"Type D personality: the heart, stress, and cortisol","volume":"98","author":"Sher","year":"2005","journal-title":"QJM"},{"key":"B38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","article-title":"Anxiety and risk of incident coronary heart disease: a meta-analysis","volume":"56","author":"Roest","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/2047487316670918","article-title":"Association of depression and anxiety status with 10-year cardiovascular disease incidence among apparently healthy Greek adults: the ATTICA study","volume":"24","author":"Kyrou","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/08870446.2020.1779273","article-title":"Anxiety as a risk factor for cardiovascular disease independent of depression: a prospective examination of community-dwelling men (the MrOS study)","volume":"36","author":"Karlsen","year":"2021","journal-title":"Psychol Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1440-1819.2009.01974.x","article-title":"Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study","volume":"63","author":"Huang","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2055102914557658","DOI":"10.1177\/2055102914557658","article-title":"Anhedonic depression, history of depression, and anxiety as gender-specific risk factors of myocardial infarction in healthy men and women: the HUNT study","volume":"1","author":"Langvik","year":"2014","journal-title":"Health Psychol Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.psychres.2011.05.018","article-title":"GAD is good? Generalized anxiety disorder predicts a superior five-year outcome following an acute coronary syndrome","volume":"188","author":"Parker","year":"2011","journal-title":"Psychiatry Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1192\/bjp.bp.114.156554","article-title":"Anxiety and new onset of cardiovascular disease: critical review and meta-analysis","volume":"208","author":"Batelaan","year":"2016","journal-title":"Br J Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCRESAHA.119.315813","article-title":"Brain damage with heart failure: cardiac biomarker alterations and gray matter decline","volume":"126","author":"Mueller","year":"2020","journal-title":"Circ Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"852891","DOI":"10.3389\/fphys.2022.852891","article-title":"Autonomic neural circuit and intervention for comorbidity anxiety and cardiovascular disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front Physiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neuroimage.2019.04.014","article-title":"The relationship between heart rate and functional connectivity of brain regions involved in autonomic control","volume":"196","author":"de la Cruz","year":"2019","journal-title":"Neuroimage"},{"key":"B48","doi-asserted-by":"publisher","first-page":"691988","DOI":"10.3389\/fnins.2021.691988","article-title":"The influence of heart rate variability biofeedback on cardiac regulation and functional brain connectivity","volume":"15","author":"Schumann","year":"2021","journal-title":"Front Neurosci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1067\/mhj.2000.109981","article-title":"Heart rate variability in depressive and anxiety disorders","volume":"140","author":"Gorman","year":"2000","journal-title":"Am Heart J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/ajh\/hpv047","article-title":"State of the art review: depression, stress, anxiety, and cardiovascular disease","volume":"28","author":"Cohen","year":"2015","journal-title":"Am J Hypertens"},{"key":"B51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.psyneuen.2017.02.035","article-title":"Depression and anxiety both associate with serum level of hs-CRP: a gender-stratified analysis in a population-based study","volume":"81","author":"Tayefi","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2005.06.001","article-title":"Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study","volume":"185","author":"Pitsavos","year":"2006","journal-title":"Atherosclerosis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/PSY.0b013e318219e64e","article-title":"Major depressive disorder, anxiety disorders, and cardiac biomarkers in subjects at high risk of obstructive sleep apnea","volume":"73","author":"Einvik","year":"2011","journal-title":"Psychosom Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/QCO.0b013e328344f50f","article-title":"Inflammation and cardiac outcome","volume":"24","author":"Hohensinner","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10803-017-3358-z","article-title":"Brief report: physical activity, body mass Index and arterial stiffness in children with autism spectrum disorder: preliminary findings","volume":"48","author":"Heffernan","year":"2018","journal-title":"J Autism Dev Disord"},{"key":"B56","doi-asserted-by":"publisher","first-page":"383","DOI":"10.9758\/cpn.2018.16.4.383","article-title":"The levels of vitamin D, vitamin D receptor, homocysteine and Complex B vitamin in children with autism Spectrum disorders","volume":"16","author":"Altun","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000492900","article-title":"Homocysteine level in children with classic congenital adrenal hyperplasia: relationship to carotid intimal wall thickness and left ventricular function","volume":"90","author":"Metwalley","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jsha.2017.11.007","article-title":"Prognostic value of homocysteine and highly sensitive cardiac troponin T in children with acute heart failure","volume":"30","author":"El-Amrousy","year":"2018","journal-title":"J Saudi Heart Assoc"},{"key":"B59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/17518423.2023.2181417","article-title":"Assessment of sonographic carotid parameters in autism spectrum disorder: a comparative case control study","volume":"26","author":"Imre Yetkin","year":"2023","journal-title":"Dev Neurorehabil"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1017\/erm.2023.15","article-title":"Dysregulated phosphate metabolism in autism spectrum disorder: associations and insights for future research","volume":"25","author":"Brown","year":"2023","journal-title":"Expert Rev Mol Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40519-018-0567-1","article-title":"Anorexia nervosa and heart disease: a systematic review","volume":"24","author":"Giovinazzo","year":"2019","journal-title":"Eat Weight Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1192\/bjp.2023.90","article-title":"Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study","volume":"223","author":"Thapar","year":"2023","journal-title":"Br J Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jad.2012.01.005","article-title":"Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder","volume":"138","author":"Slomka","year":"2012","journal-title":"J Affect Disord"},{"key":"B64","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2020.12.066","article-title":"Risk of specific cardiovascular diseases in obsessive-compulsive disorder","volume":"135","author":"Isomura","year":"2021","journal-title":"J Psychiatr Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/02537176211042805","article-title":"Cardiovascular autonomic function tests in patients of obsessive-compulsive disorder: a cross-sectional study","volume":"44","author":"Sandhya","year":"2022","journal-title":"Indian J Psychol Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijcard.2016.11.209","article-title":"Gender and age differences in cardiovascular complications in anorexia nervosa patients","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00115-020-00900-5","article-title":"[Adult attention deficit hyperactivity disorder and comorbidity: new findings on epidemiological and genetic factors]","volume":"91","author":"Kittel-Schneider","year":"2020","journal-title":"Nervenarzt"},{"key":"B68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","article-title":"Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine","volume":"31","author":"Hennissen","year":"2017","journal-title":"CNS Drugs"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1329463\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T10:20:35Z","timestamp":1721384435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1329463\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":68,"alternative-id":["10.3389\/fcvm.2024.1329463"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1329463","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"article-number":"1329463"}}